Tue, May 13, 9:25 PM (40 days ago)
**CQENS Technologies Inc. (CQENS) Q1 2025 Financial Summary** **Financial Health & Performance:** - **Revenue:** No revenue generated in Q1 2025 or Q1 2024. - **Net Loss:** Increased by 150.6% to $2,493,777 in Q1 2025 from $995,765 in Q1 2024. - **Operating Expenses:** Increased by 158.3% to $2,572,118 in Q1 2025, driven by professional fees and stock compensation. - **Cash Position:** Increased to $11,847,746 in Q1 2025 from $4,596,556 in Q1 2024, due to stock sales and related party borrowings. - **Working Capital:** Surplus of $10,346,269 in Q1 2025, up from $1,575,975 in Q1 2024. - **Accumulated Deficit:** Increased to $37,242,946 in Q1 2025. **Profit Margins & Cash Flow:** - **Operating Margin:** Negative, with operating losses increasing. - **Cash Flow from Operations:** Negative $1,886,956 in Q1 2025, up from negative $350,447 in Q1 2024. - **Cash Flow from Financing:** Positive $9,285,612 in Q1 2025, driven by stock sales. **Earnings Changes & Trends:** - **Earnings per Share (EPS):** Basic and diluted loss per share increased to $0.09 in Q1 2025 from $0.04 in Q1 2024. - **Trends:** Increasing operating expenses and net losses, with no revenue generation. **Future Operations & Uncertainties:** - **Capital Raising:** Needs to raise $10,000,000 to $15,000,000 in the next 12 months to continue operations. - **Going Concern:** Substantial doubt about the ability to continue as a going concern due to recurring losses and lack of revenue. - **Strategic Partnerships:** Dependent on entering into additional strategic partnerships for future growth. - **Regulatory Submissions:** Plans to file regulatory submissions with the US FDA. - **Market Tests:** Plans to undertake market tests in the EU. - **Recessionary Pressures:** Potential impact of recessionary conditions on capital raising efforts. **Stock Information:** - **Shares Outstanding:** 27,377,302 as of May 13, 2025. - **Stock Sales:** Sold 503,750 shares for $10,075,000 in Q1 2025 and an additional 5,000 shares for $100,000 post-Q1. **Ticker:** CQENS **Conclusion:** CQENS Technologies Inc. faces significant financial challenges, with increasing losses and no revenue generation. The company's ability to continue as a going concern is dependent on raising substantial additional capital and entering into strategic partnerships. The impact of recessionary conditions and regulatory hurdles adds further uncertainty to the company's future operations.